Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**Ribosomal protein L7a pseudogene 19** (RPL7AP19) is a processed pseudogene in the human genome located on chromosome 1[4][11]. Unlike protein-coding genes, pseudogenes such as RPL7AP19 do not produce a functional protein product. RPL7AP19 arises from the parental gene RPL7A, which encodes a component of the large (60S) ribosomal subunit, but RPL7AP19 itself is not translated into a functional protein and currently has no known biological function or therapeutic relevance[1][4][11]. There are multiple such processed pseudogenes for ribosomal protein genes scattered throughout the genome[3][12].\n\n**Key points:**\n- RPL7AP19 is a pseudogene—the product of a gene duplication or retrotransposition event, which is generally nonfunctional in terms of protein production.\n- It is not a receptor, enzyme, transporter, or any molecule with a known role in biological signaling or therapeutics.\n- There are no documented interactions with drugs, disease associations, or identified utility as a biomarker.\n- Therapeutic targeting, disease roles, or safety concerns are not applicable because it does not encode a functional protein or have a demonstrated biological role[1][4][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L7a pseudogene 19 (RPL7AP19).